Skip to main content

Table 2 Frequency of BRAF somatic mutations according to patients’ characteristics

From: Discrepant alterations in main candidate genes among multiple primary melanomas

Subgroups

(No. of samples)

Cases positive to BRAF mutations

No.

%

P

All samples

(229)

109

47.6

 

Sex

  

 Male

(107)

50

46.7

0.809

 Female

(122)

59

48.4

Site of primary melanoma

  

 Head-neck

(20)

9

45.0

0.623

 Trunk

(129)

58

44.9

 Limbs

(86)

42

48.8

Number of primary tumors

  

 2 melanomas (186)

 

86

46.2

0.172

 ≥ 3 melanomas (43)

 

23

53.5

Type of melanoma

  

 Synchronous

(40)

18

45.0

0.208

 Asynchronous

(189)

91

48.1

AJCC disease stage

  

 ≤ I

(161)

72

44.7

0.276

 ≥ II

(78)

37

47.4

Age at diagnosis

  

 < 40 years

(34)

18

52.9

0.089

 40-50 years

(52)

25

48.1

 > 50 years

(143)

66

46.2

Family history of melanoma

  

1 affected members

(193)

92

47.7

0.962

≥ 2 affected members

(36)

17

47.2

  1. Disease stage was defined according to the recent American Joint Committee on Cancer (AJCC) guidelines. P: chi-squared test; two tailed; 95% confidence interval.